Back to Agenda
SESSION 3
Session Chair(s)
Toshiyoshi Tominaga, PhD
Life Science Department, Advisor, Sunflare, Japan
Session 3
Speaker(s)
Panel Discussion
Pär Tellner, MPharm, MSc, RPh
Director, Regulatory Affairs, EFPIA, Belgium
E9 Improving Planning, Conduct, Analysis and Interpretation of Clinical Trials
Steven Teerenstra, PhD, MSc
Statistician, Medicines Evaluation Board, Netherlands
E14 Clinical Evaluation of QT/QTc
Corina Dana Dota, MD
AZ ECG Centre Director, AstraZeneca R&D Molndal, Sweden
M4E (CTD) Benefit-Risk Information
Filip Mussen, PhD
Vice President, Regional Regulatory Affairs, Janssen R&D, Pharmaceutical Companies of Johnson & Johnson, Belgium
Panel Discussion
Tomas Salmonson, DrMed, PhD
, Critical Path Institute, Netherlands
Have an account?